CN1060293A - 血纤维蛋白原受体拮抗剂 - Google Patents

血纤维蛋白原受体拮抗剂 Download PDF

Info

Publication number
CN1060293A
CN1060293A CN91109394A CN91109394A CN1060293A CN 1060293 A CN1060293 A CN 1060293A CN 91109394 A CN91109394 A CN 91109394A CN 91109394 A CN91109394 A CN 91109394A CN 1060293 A CN1060293 A CN 1060293A
Authority
CN
China
Prior art keywords
thrombocyte
mammals
composition
gets
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN91109394A
Other languages
English (en)
Chinese (zh)
Inventor
M·E·达根
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of CN1060293A publication Critical patent/CN1060293A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN91109394A 1990-09-27 1991-09-26 血纤维蛋白原受体拮抗剂 Pending CN1060293A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58928290A 1990-09-27 1990-09-27
US589,282 1990-09-27

Publications (1)

Publication Number Publication Date
CN1060293A true CN1060293A (zh) 1992-04-15

Family

ID=24357362

Family Applications (1)

Application Number Title Priority Date Filing Date
CN91109394A Pending CN1060293A (zh) 1990-09-27 1991-09-26 血纤维蛋白原受体拮抗剂

Country Status (15)

Country Link
EP (1) EP0479481A3 (fi)
JP (1) JPH0517498A (fi)
KR (1) KR920006373A (fi)
CN (1) CN1060293A (fi)
AU (1) AU8477891A (fi)
CA (1) CA2052057A1 (fi)
CS (1) CS294791A3 (fi)
FI (1) FI914532A (fi)
HU (1) HUT60751A (fi)
IE (1) IE913380A1 (fi)
IL (1) IL99539A0 (fi)
MX (1) MX9101311A (fi)
NO (1) NO913786L (fi)
PT (1) PT99095A (fi)
ZA (1) ZA917695B (fi)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU666318B2 (en) * 1991-06-28 1996-02-08 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
US5939412A (en) * 1992-06-26 1999-08-17 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
US5340798A (en) * 1992-10-14 1994-08-23 Merck & Co., Inc. Fibrinogen receptor antagonists
EP0667773A4 (en) * 1992-10-14 1996-09-25 Merck & Co Inc FIBRINOGEN RECEPTOR ANTAGONISTS.
US5358956A (en) * 1992-10-14 1994-10-25 Merck & Co., Inc. Fibrinogen receptor antagonists
EP0664792B1 (en) * 1992-10-14 2000-01-05 Merck & Co. Inc. Fibrinogen receptor antagonists
CA2150550A1 (en) * 1992-12-01 1994-06-09 Melissa S. Egbertson Fibrinogen receptor antagonists
NZ262942A (en) * 1993-03-29 1997-07-27 Zeneca Ltd Pyridyl substituted piperazine and various other derivatives of azaheteroaryl substituted piperazines; pharmaceutical compositions
US5652242A (en) * 1993-03-29 1997-07-29 Zeneca Limited Heterocyclic derivatives
SK120895A3 (en) * 1993-03-29 1996-06-05 Zeneca Ltd Pyridine derivatives, process for preparing the same and intermediate products in this process and pharmaceutical compositions containing them
US5753659A (en) * 1993-03-29 1998-05-19 Zeneca Limited Heterocyclic compouds
US5750754A (en) * 1993-03-29 1998-05-12 Zeneca Limited Heterocyclic compounds
US5334596A (en) * 1993-05-11 1994-08-02 Merck & Co., Inc. Fibrinogen receptor antagonists
US5463011A (en) * 1993-06-28 1995-10-31 Zeneca Limited Acid derivatives
GB9313285D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Acid derivatives
GB9313268D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Chemical compounds
US5397791A (en) * 1993-08-09 1995-03-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US6274705B1 (en) 1996-05-02 2001-08-14 Aventis Pharmaceuticals Products Inc. Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
DK0812205T3 (da) * 1993-10-15 2001-04-17 Rhone Poulenc Rorer Pharma Antithrombotiske azacycloalkylalkanoylpeptider og -pseudopeptider
US5780590A (en) * 1993-10-15 1998-07-14 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
MA23420A1 (fr) * 1994-01-07 1995-10-01 Smithkline Beecham Corp Antagonistes bicycliques de fibrinogene.
US6458784B1 (en) 1994-06-29 2002-10-01 Smithkline Beecham Corporation Vitronectin receptor antagonists
US5451578A (en) * 1994-08-12 1995-09-19 Merck & Co., Inc. Fibrinogen receptor antagonists
US5525617A (en) * 1994-08-24 1996-06-11 Merck & Co., Inc. Fibrinogen receptor antagonists
US5977101A (en) * 1995-06-29 1999-11-02 Smithkline Beecham Corporation Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity
US5789421A (en) * 1995-10-26 1998-08-04 Merck & Co., Inc. Fibrinogen receptor antagonist
US5780480A (en) * 1996-02-28 1998-07-14 Merck & Co., Inc. Fibrinogen receptor antagonists
AP1390A (en) * 1996-11-27 2005-04-15 Aventis Pharmaceuticals Products Inc Pharmaceutical composition comprising a compound having anti-Xa activity and a platelet aggregation antagonist compound.
EP1747219A4 (en) * 2004-05-13 2010-05-26 Glaxo Group Ltd Antagonists of muscarinic acetylcholine receptor

Also Published As

Publication number Publication date
ZA917695B (en) 1992-05-27
FI914532A (fi) 1992-03-28
JPH0517498A (ja) 1993-01-26
EP0479481A2 (en) 1992-04-08
IL99539A0 (en) 1992-08-18
NO913786L (no) 1992-03-30
NO913786D0 (no) 1991-09-26
IE913380A1 (en) 1992-04-08
PT99095A (pt) 1992-08-31
MX9101311A (es) 1992-05-04
EP0479481A3 (en) 1993-07-28
CS294791A3 (en) 1992-04-15
HUT60751A (en) 1992-10-28
FI914532A0 (fi) 1991-09-26
HU913074D0 (en) 1992-01-28
AU8477891A (en) 1992-04-02
KR920006373A (ko) 1992-04-27
CA2052057A1 (en) 1992-03-28

Similar Documents

Publication Publication Date Title
CN1060293A (zh) 血纤维蛋白原受体拮抗剂
JP2531562B2 (ja) フィブリノ―ゲン受容体拮抗剤
EP0502926B1 (en) Anti-thrombotic peptides and pseudopeptides
JP2755351B2 (ja) 抗―凝集ペプチド
JP2700511B2 (ja) Ｈｉｖプロテアーゼ阻害剤
CN1169809C (zh) Boc保护的β-四氢咔啉羧酸及纳米制剂和RGD缀合物，其制备方法和用途
PT99096A (pt) Processo para a preparacao de antagonistas de receptores de fibrinogenio, por exemplo derivados de alanina
CN1052730C (zh) 具有生长激素释放特性的化合物
JPH09505601A (ja) インドリル基含有化合物類および成長ホルモン放出を促進するためのそれらの使用
JPH09509937A (ja) 抗血栓剤
JP2001322974A (ja) ４−アミノメチル−１−アミジノベンゼン化合物
CN1309633A (zh) 作为整合素抑制剂的二酰基肼衍生物
JPH07116144B2 (ja) フィブリノーゲン受容体拮抗薬
JPH06263797A (ja) 生物活性環化ポリペプチド
US20040210051A1 (en) N-alkanoylphenylalanine derivatives
RU2178419C2 (ru) Ингибиторы протеазы серина
CN1347325A (zh) 用作生长激素促分泌剂的新酰胺衍生物
US4855303A (en) Fluorine containing renin inhibitors
CN1261895A (zh) 具有拮抗作用的环氮杂肽
CN85107088A (zh) 肽取代的杂环免疫刺激剂的制备
CN1198748A (zh) 多氟烷基色氨酸三肽凝血酶抑制剂
JP2002505320A (ja) マトリックスメタロプロテイナーゼ阻害剤
CN1055479C (zh) 心血管活性多肽以及它们的合成和在医学中的应用
EP1420029A2 (fr) Procédé de synthèse du perindopril et ses sels pharmaceutiquement acceptables
CN1200736A (zh) 肽衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication